1. Home
  2. |Insights
  3. |GAO Defers to Agency on Impact of Sequestration

GAO Defers to Agency on Impact of Sequestration

Client Alert | 1 min read | 12.06.13

In Vinculum Solutions, Inc.—Reconsideration (Dec. 3, 2013), GAO reconfirmed its conclusion in the first published decision on the issue (previously discussed here) that an agency's need to reduce costs due to sequestration may be a valid basis for canceling a solicitation. Of particular relevance for future protests, GAO rejected the argument that GAO should have sought the specific budget and funding data that supported the agency's cancellation decision, noting that, in the protest context, GAO "generally does not question" an agency's representations regarding its budget and funding choices.

Insights

Client Alert | 3 min read | 01.21.26

Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement

On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion....